Cargando…
The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168937/ https://www.ncbi.nlm.nih.gov/pubmed/25247121 http://dx.doi.org/10.3762/bjnano.5.151 |
_version_ | 1782335645002235904 |
---|---|
author | Docter, Dominic Bantz, Christoph Westmeier, Dana Galla, Hajo J Wang, Qiangbin Kirkpatrick, James C Nielsen, Peter Maskos, Michael Stauber, Roland H |
author_facet | Docter, Dominic Bantz, Christoph Westmeier, Dana Galla, Hajo J Wang, Qiangbin Kirkpatrick, James C Nielsen, Peter Maskos, Michael Stauber, Roland H |
author_sort | Docter, Dominic |
collection | PubMed |
description | Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry. Here, the physico-chemical characteristics of NP are widely discussed as critical determinants, albeit the exact mechanisms remain to be resolved. Moreover, proteins associate with NP in physiological fluids, forming the protein corona potentially transforming the biological identity of the particle and thus, adding an additional level of complexity for the bio–nano responses. Here, we employed amorphous silica nanoparticles (ASP) and epithelial GI tract Caco-2 cells as a model to study the biological impact of particle size as well as of the protein corona. Caco-2 or mucus-producing HT-29 cells were exposed to thoroughly characterized, negatively charged ASP of different size in the absence or presence of proteins. Comprehensive experimental approaches, such as quantifying cellular metabolic activity, microscopic observation of cell morphology, and high-throughput cell analysis revealed a dose- and time-dependent toxicity primarily upon exposure with ASP30 (Ø = 30 nm). Albeit smaller (ASP20, Ø = 20 nm) or larger particles (ASP100; Ø = 100 nm) showed a similar zeta potential, they both displayed only low toxicity. Importantly, the adverse effects triggered by ASP30/ASP30L were significantly ameliorated upon formation of the protein corona, which we found was efficiently established on all ASP studied. As a potential explanation, corona formation reduced ASP30 cellular uptake, which was however not significantly affected by ASP surface charge in our model. Collectively, our study uncovers an impact of ASP size as well as of the protein corona on cellular toxicity, which might be relevant for processes at the nano–bio interface in general. |
format | Online Article Text |
id | pubmed-4168937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Beilstein-Institut |
record_format | MEDLINE/PubMed |
spelling | pubmed-41689372014-09-22 The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles Docter, Dominic Bantz, Christoph Westmeier, Dana Galla, Hajo J Wang, Qiangbin Kirkpatrick, James C Nielsen, Peter Maskos, Michael Stauber, Roland H Beilstein J Nanotechnol Full Research Paper Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry. Here, the physico-chemical characteristics of NP are widely discussed as critical determinants, albeit the exact mechanisms remain to be resolved. Moreover, proteins associate with NP in physiological fluids, forming the protein corona potentially transforming the biological identity of the particle and thus, adding an additional level of complexity for the bio–nano responses. Here, we employed amorphous silica nanoparticles (ASP) and epithelial GI tract Caco-2 cells as a model to study the biological impact of particle size as well as of the protein corona. Caco-2 or mucus-producing HT-29 cells were exposed to thoroughly characterized, negatively charged ASP of different size in the absence or presence of proteins. Comprehensive experimental approaches, such as quantifying cellular metabolic activity, microscopic observation of cell morphology, and high-throughput cell analysis revealed a dose- and time-dependent toxicity primarily upon exposure with ASP30 (Ø = 30 nm). Albeit smaller (ASP20, Ø = 20 nm) or larger particles (ASP100; Ø = 100 nm) showed a similar zeta potential, they both displayed only low toxicity. Importantly, the adverse effects triggered by ASP30/ASP30L were significantly ameliorated upon formation of the protein corona, which we found was efficiently established on all ASP studied. As a potential explanation, corona formation reduced ASP30 cellular uptake, which was however not significantly affected by ASP surface charge in our model. Collectively, our study uncovers an impact of ASP size as well as of the protein corona on cellular toxicity, which might be relevant for processes at the nano–bio interface in general. Beilstein-Institut 2014-08-27 /pmc/articles/PMC4168937/ /pubmed/25247121 http://dx.doi.org/10.3762/bjnano.5.151 Text en Copyright © 2014, Docter et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjnano/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Nanotechnology terms and conditions: (https://www.beilstein-journals.org/bjnano/terms) |
spellingShingle | Full Research Paper Docter, Dominic Bantz, Christoph Westmeier, Dana Galla, Hajo J Wang, Qiangbin Kirkpatrick, James C Nielsen, Peter Maskos, Michael Stauber, Roland H The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
title | The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
title_full | The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
title_fullStr | The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
title_full_unstemmed | The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
title_short | The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
title_sort | protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles |
topic | Full Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168937/ https://www.ncbi.nlm.nih.gov/pubmed/25247121 http://dx.doi.org/10.3762/bjnano.5.151 |
work_keys_str_mv | AT docterdominic theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT bantzchristoph theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT westmeierdana theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT gallahajoj theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT wangqiangbin theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT kirkpatrickjamesc theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT nielsenpeter theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT maskosmichael theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT stauberrolandh theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT docterdominic proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT bantzchristoph proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT westmeierdana proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT gallahajoj proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT wangqiangbin proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT kirkpatrickjamesc proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT nielsenpeter proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT maskosmichael proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles AT stauberrolandh proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles |